Optellum, a leader in AI-enabled lung cancer risk assessment, is pleased to announce its selection in a landmark NHS initiative that combines Optellum's AI-driven lung cancer risk stratification with ...
Lung cancer is one of the most common types of cancer in the United States and a leading cause of cancer deaths, but the ...
Dr. Nathan Pennell and Dr. Cheryl Czerlanis discuss challenges in lung cancer screening and potential solutions to increase screening rates, including the use of AI to enhance risk prediction and ...
It started with a bit of blood. In April 2013, then 68-year-old John Ryan checked in with his primary care physician after he suddenly began to cough up trace amounts of blood. One emergency room trip ...
Most lung cancer in the U.S. is diagnosed at Stage 4, after the leading cause of cancer deaths has spread to other parts of the body. However, a Maryland health system is outpacing national averages ...
In an interview with CURE, Clara Cirks shares the emotional weight of finishing chemo while facing ongoing immunotherapy and the uncertainty it brings. On Tuesday, January 28, 2025, 30-year-old Clara ...